Galapagos NV (GLPG) Financials

GLPG Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 4.7 billion 1.9 billion
2023-06-30 4.9 billion 2.1 billion
2023-03-31 5.0 billion 2.3 billion
2022-12-31 5.1 billion 2.4 billion

GLPG Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -129.2 million -29.2 million
2023-06-30 -140.5 million 30.0 million
2023-03-31 -108.1 million ?
2022-12-31 -201.4 million 40.2 million

GLPG Net Income

No data available :(

GLPG Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 4.0 billion - 15.0 million
2023-06-30 4.2 billion - 16.8 million
2023-03-31 4.3 billion - 17.4 million
2022-12-31 4.4 billion - 23.5 million

GLPG Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 70.2 million
2023-06-30 71.2 million
2023-03-31 72.3 million
2022-12-31 70.1 million

GLPG Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 3.4 million 106.2 million 17.5 million 72.1 million
2023-06-30 4.1 million 117.8 million 52.4 million 9.6 million
2023-03-31 4.7 million 112.8 million 31.9 million 31.4 million
2022-12-31 8.4 million 162.1 million 62.8 million 17.3 million

GLPG Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 127.1 million 6.0 million
2023-06-30 163.0 million 4.6 million
2023-03-31 195.0 million 3.9 million
2022-12-31 102.1 million 4.4 million

GLPG

Price: $29.09

52 week price:
28.45
45.21

Earnings Per Share: -2.54 USD

P/E Ratio: -15.32

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 69406

Ebitda: -23.5 million

Market Capitalization: 2.1 billion

Links: